Kezar Life Sciences, Inc. (KZR) Long-Term Debt Repayments (2025)

Kezar Life Sciences has reported Long-Term Debt Repayments for 1 years, with the latest figure at $6.7 million in Q4 2025.

• Quarterly Long-Term Debt Repayments changed N/A year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $9.3 million (up 616.72% YoY) and the FY2025 annual result came in at $10.6 million, changed N/A from the prior year.
• Long-Term Debt Repayments grew to $6.7 million in Q4 2025 per KZR's latest filing, from $1.3 million in the prior quarter.
• Over five years, Long-Term Debt Repayments peaked at $6.7 million in Q4 2025 and troughed at $1.3 million in Q1 2025.